Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

25316-40-9Doxorubicin Hydrochloride Working Standard (Secondary Reference Standard)

● Under Development

Catalogue No.:	VE0026904
CAS No.:	25316-40-9
Mol. Formula:	C27H30ClNO11
Mol. Weight:	579.98 g/mol

How can we help?

Add to RFQ list

Additional information on CAS 25316-40-9

Parent drug

Doxorubicin / Doxorubicin Hydrochloride

IUPAC Name

(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride

Smiles

O[C@@H]1[C@H](C)O[C@@H](O[C@]2([H])C3=C(O)C4=C(C(C(C=CC=C5OC)=C5C4=O)=O)C(O)=C3C[C@](C(CO)=O)(O)C2)C[C@@H]1N.Cl

InChI

InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1

Description

Doxorubicin Hydrochloride Working Standard (Secondary Reference Standard), CAS 25316-40-9, is supplied as a fully characterized, traceable material intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies. Each lot is delivered with a Certificate of Analysis documenting validated HPLC assay, specified impurity profile, residual solvent and water content, and mass balance metrics. Manufacturing traceability, lot numbering and recommended storage and handling conditions are provided to ensure reproducible analytical performance under non-regulatory laboratory quality systems.